62.90
前日終値:
$63.31
開ける:
$62.18
24時間の取引高:
302.04K
Relative Volume:
0.47
時価総額:
$1.34B
収益:
$56.54M
当期純損益:
$-30.70M
株価収益率:
-161.28
EPS:
-0.39
ネットキャッシュフロー:
$-31.05M
1週間 パフォーマンス:
+1.70%
1か月 パフォーマンス:
+28.29%
6か月 パフォーマンス:
+238.63%
1年 パフォーマンス:
+387.98%
Cidara Therapeutics Inc Stock (CDTX) Company Profile
名前
Cidara Therapeutics Inc
セクター
電話
858-752-6170
住所
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
CDTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CDTX
Cidara Therapeutics Inc
|
62.90 | 1.40B | 56.54M | -30.70M | -31.05M | -0.39 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-18 | 再開されました | H.C. Wainwright | Buy |
2025-03-12 | 開始されました | Citizens JMP | Mkt Outperform |
2025-01-27 | 再開されました | Cantor Fitzgerald | Overweight |
2024-12-13 | 開始されました | RBC Capital Mkts | Outperform |
2024-11-08 | 開始されました | Guggenheim | Buy |
2024-08-14 | アップグレード | H.C. Wainwright | Neutral → Buy |
2021-12-03 | 再開されました | H.C. Wainwright | Buy |
2021-09-22 | アップグレード | WBB Securities | Buy → Strong Buy |
2021-03-04 | 開始されました | Aegis Capital | Buy |
2019-09-04 | アップグレード | Wedbush | Neutral → Outperform |
2018-07-26 | 開始されました | Citigroup | Buy |
2017-04-21 | 開始されました | Raymond James | Strong Buy |
2017-04-17 | 繰り返されました | H.C. Wainwright | Buy |
2017-04-12 | 開始されました | Ladenburg Thalmann | Buy |
2017-04-11 | 再開されました | Wedbush | Outperform |
2017-02-22 | 繰り返されました | H.C. Wainwright | Buy |
2017-02-22 | アップグレード | WBB Securities | Sell → Hold |
2016-12-21 | 再開されました | Leerink Partners | Outperform |
2016-12-19 | 開始されました | H.C. Wainwright | Buy |
2016-09-23 | ダウングレード | WBB Securities | Hold → Sell |
2015-10-09 | アップグレード | WBB Securities | Sell → Hold |
2015-05-11 | 開始されました | Jefferies | Buy |
2015-05-11 | 開始されました | Leerink Partners | Outperform |
2015-05-11 | 開始されました | Needham | Buy |
2015-05-11 | 開始されました | Wedbush | Outperform |
2015-04-23 | 開始されました | WBB Securities | Sell |
すべてを表示
Cidara Therapeutics Inc (CDTX) 最新ニュース
Will Cidara Therapeutics Inc. Bounce From 52 Week LowTriple Digit Growth Focused Trade Plan Reviewed - metal.it
Moving Average Crossover Confirms Uptrend in Cidara Therapeutics Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
How Cidara Therapeutics Inc. stock performs during market volatilityHigh Win Rate Trading Opportunities Detected - beatles.ru
Can trapped investors hope for a rebound in Cidara Therapeutics Inc.Real-Time Trade Insights Spark Market Reactions - metal.it
Will Cidara Therapeutics Inc. stock split in the near futureInvestment Strategy With Predictable Gains Outlined - metal.it
Candidemia Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Cidara Therapeutics, Scynexis, Merck, Basilea Pharmaceutica, Lupin Pharmaceuticals, Astellas PharmaResearchAndMarkets.com - FinancialContent
Why Cidara Therapeutics Inc. stock attracts strong analyst attentionBuy Signal Based on Chart Analysis Confirmed - metal.it
Why is Cidara Therapeutics Inc. stock attracting strong analyst attentionFree Market Volatility Navigation Tips - jammulinksnews.com
What is Cidara Therapeutics Inc. company’s growth strategySwing Trade Updates To Watch Now - jammulinksnews.com
What institutional investors are buying Cidara Therapeutics Inc. stockBuild wealth with reliable stock picks - jammulinksnews.com
What are analysts’ price targets for Cidara Therapeutics Inc. in the next 12 monthsUnlock powerful stock screening for profits - jammulinksnews.com
What makes Cidara Therapeutics Inc. stock price move sharplyOutstanding risk-reward balance - jammulinksnews.com
Is Cidara Therapeutics Inc. stock overvalued or undervaluedUnlock expert stock analysis and alerts - jammulinksnews.com
Why Cidara Therapeutics Inc. stock attracts strong analyst attention Fundamental + Technical Combined Watchlist - metal.it
What is the dividend policy of Cidara Therapeutics Inc. stockInvest confidently with real-time data analysis - jammulinksnews.com
How strong is Cidara Therapeutics Inc. company’s balance sheetTrack emerging stocks with high growth potential - jammulinksnews.com
Published on: 2025-07-28 06:14:55 - jammulinksnews.com
How does Cidara Therapeutics Inc. compare to its industry peersDiscover breakthrough trading strategies - jammulinksnews.com
What are Cidara Therapeutics Inc. company’s key revenue driversRapid capital growth - jammulinksnews.com
Published on: 2025-07-27 22:06:43 - jammulinksnews.com
Should I hold or sell Cidara Therapeutics Inc. stock in 2025Get real-time alerts on top-performing stocks - jammulinksnews.com
Cidara Therapeutics Announces Q2 2025 Financial Results Release and Upcoming Conference Call - AInvest
Cidara Therapeutics Inc. Stock Analysis and ForecastHigh-profit stock alerts - PrintWeekIndia
What drives Cidara Therapeutics Inc. stock priceTriple-digit growth rates - PrintWeekIndia
Will Cidara Therapeutics Inc. stock benefit from interest rate changesRapid market gains - jammulinksnews.com
What analysts say about Cidara Therapeutics Inc. stockRapid market gains - PrintWeekIndia
Cidara Therapeutics to Report Second Quarter 2025 Financial - GlobeNewswire
Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025 - 富途牛牛
Cidara Therapeutics Sets Q2 Earnings Date: Key Updates on DFC Immunotherapy Platform Expected - Stock Titan
Is Cidara Therapeutics Inc. a good long term investmentMarket-beating returns - Autocar Professional
Cidara more than doubles on phase 2 flu preventative data - MSN
Cidara Therapeutics Inc (CDTX) 財務データ
収益
当期純利益
現金流量
EPS
Cidara Therapeutics Inc (CDTX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Mineo Chrysa | Director |
Jun 02 '25 |
Buy |
21.71 |
2,270 |
49,281 |
2,270 |
Mineo Chrysa | Director |
Jun 03 '25 |
Buy |
23.44 |
1,050 |
24,614 |
3,320 |
Ward Shane | COO & CLO |
Mar 11 '25 |
Sale |
21.96 |
1,664 |
36,542 |
14,674 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER |
Mar 11 '25 |
Sale |
21.96 |
1,773 |
38,940 |
16,215 |
Sandison Taylor | Chief Medical Officer |
Sep 11 '24 |
Sale |
11.64 |
924 |
10,752 |
23,067 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER |
Sep 11 '24 |
Sale |
11.64 |
909 |
10,580 |
17,788 |
大文字化:
|
ボリューム (24 時間):